journavx pain management - Search News

FDA approves new pain medication

U.S. News & World Report · 31m

What to Know: FDA Approves Non-Opioid Pain Medication, Journavx

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

USA TODAY on MSN · 5h

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

FDA approves nonopioid Journavx for moderate to severe acute pain

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.The nonopioid analgesic suzetrigine (Journavx, Vertex Pharmaceuticals),

Psychology Today2h

Treating Pain—Avoiding the Brain

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

BioPharma Dive3h

A new, non-opioid pain drug is here. Getting it to patients could be agony.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results